InvestorsHub Logo
Followers 79
Posts 24524
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 10/17/2019 8:17:58 AM

Thursday, October 17, 2019 8:17:58 AM

Post# of 27431
PLX - .181 Pre-market now at .24/.2478

Protalix BioTherapeutics Announces Positive 12-Month Interim Data From BRIDGE Phase III Open Label Switch-Over Study Showing Pegunigalsidase Alfa For The Treatment Of Fabry Disease Was Well Tolerated

https://www.tradescores.com/StockReport/plx

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.